JUN 10, 2019 8:44 AM PDT

New discovery sheds light for precision medicine in cancer

A recent study published in Cancer Research highlights findings of a molecular indicator that could provide a new way for doctors to help predict how patients will respond to certain anticancer drugs. The research comes from scientists at Université de Montreal and could pave the way for novel methods of precision medicine.

The molecular indicator is composed of a group of enzymes called SRC kinases, which work to chemically modify a tumor-suppressing protein called SOCS1.

"SOCS1 is part of a gene-regulation circuit centered around the master cell proliferation regulator p53, often called the guardian of the genome," said senior author Gerardo Ferbeyre, a biochemist from Université de Montreal. "If p53 or another protein in its network is mutated or becomes chemically modified in some abnormal way, a pattern of gene activation occurs that programs cells to proliferate without control, as occurs in cancers."

This may sound complex (it is), but what it means is that the authors discovered another way in which p53 can become unbalanced, which results in the proliferation of cancer cells. This discovery will help predict if an anticancer drug could be an effective treatment for a patient’s tumor.

Subburaj Ilangumaran, a Université de Sherbrooke biochemist on the study, explained: "This new mechanism for SOCS1 inactivation may actually represent a regulatory control that is hijacked by cancer cells. On a more fundamental level, our group's discovery -- that phosphorylation of SOCS1 acquires a new physical form -- opens the door to hitherto unknown ways of regulating SOCS1 functions. And this has implications for the treatment of autoimmune diseases and for anticancer immunity."

This discovery could pave the way for new methods of precision medicine in cancer. Photo: Pixabay

UdeM PhD student Emmanuelle Saint-Germain added, "We were able to detect phosphorylated SOCS1 in patients' samples with an antibody that we developed. The same antibody could be used to detect phosphorylated SOCS1 in a clinical setting, providing a way to decide whether SRC kinase inhibitors would be an effective treatment."

Sources: Science Daily, Cancer Research

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 13, 2020
Cancer
Should we be treating kidney cancer differently?
SEP 13, 2020
Should we be treating kidney cancer differently?
New research published in the journal Clinical Cancer Research is questioning how we treat kidney tumors. According ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 05, 2020
Cancer
Does Having an Appendectomy Increase Your Risk for Cancer?
OCT 05, 2020
Does Having an Appendectomy Increase Your Risk for Cancer?
Cancer research is more than just the study of diagnostics and novel therapies. Researchers also investigate the causes ...
OCT 23, 2020
Cancer
#BCSM helps physicians understand patients' needs outside the clinical setting
OCT 23, 2020
#BCSM helps physicians understand patients' needs outside the clinical setting
A new study from UCLA published in the Journal of Patient-Centered Research and Review suggests that social media can be ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
NOV 24, 2020
Cancer
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
NOV 24, 2020
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
Did you know sleeping is great? Apparently, getting a full eight hours every night can make you look fabulous and solve ...
Loading Comments...